Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

644-highlights-from-the-tenth-european-breast-cancer-conference-ebcc10-amsterdam-9-11-march-2016

Conference Report: Highlights from the Tenth European Breast Cancer Conference (EBCC10), Amsterdam, 9–11 March 2016

Joana Ribeiro, Maria João Cardoso

3 Jun 2016

https://doi.org/10.3332/ecancer.2016.644

Abstract | Full Article | PDF

627-diagnostic-and-therapeutic-update-of-mantle-cell-lymphoma-mcl-analysis-of-seven-cases-treated-in-a-centre-in-one-year

Clinical Study: Diagnostic and therapeutic update of mantle cell lymphoma (MCL): analysis of seven cases treated in a centre in one year

Carmen Herrero-Vicent, Isidro Machado, Carmen Illueca, Amparo Avaria, Claudia Salazar, Abraham Hernandez, Sergio Sandiego, Javier Lavernia

17 Mar 2016

https://doi.org/10.3332/ecancer.2016.627

Abstract | Full Article | PDF | Spanish

618-highlights-from-the-38th-sabcs-annual-meeting-8th-12th-december-2015-san-antonio-usa

Conference Report: Highlights from the 38th SABCS annual meeting, 8th – 12th December 2015, San Antonio, USA

Linda Cairns, Giuseppe Curigliano

2 Feb 2016

https://doi.org/10.3332/ecancer.2016.618

Abstract | Full Article | PDF

610-repurposing-drugs-in-oncology-redo-diclofenac-as-an-anti-cancer-agent

Clinical Study: Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent

Pan Pantziarka, Vidula Sukhatme, Gauthier Bouche, Lydie Melhuis, Vikas P Sukhatme

11 Jan 2016

https://doi.org/10.3332/ecancer.2016.610

Abstract | Full Article | PDF

585-anti-androgenic-effects-of-flavonols-in-prostate-cancer

Review: Anti-androgenic effects of flavonols in prostate cancer

Tristan Boam

22 Oct 2015

https://doi.org/10.3332/ecancer.2015.585

Abstract | Full Article | PDF

581-aspirin-in-the-21st-century-common-mechanisms-of-disease-and-their-modulation-by-aspirin-a-report-from-the-2015-scientific-conference-of-the-international-aspirin-foundation-28-august-london-uk

Conference Report: Aspirin in the 21st century—common mechanisms of disease and their modulation by aspirin: a report from the 2015 scientific conference of the international aspirin foundation, 28 August, London, UK

Tom Smith, Pippa Hutchison, Karsten Schrör, Joan Clària, Angel Lanas, Paola Patrignani, Andrew T Chan, Farhat Din, Ruth Langley, Peter Elwood, Andrew Freedman, Ron Eccles

13 Oct 2015

https://doi.org/10.3332/ecancer.2015.581

Abstract | Full Article | PDF

568-repurposing-drugs-in-oncology-redo-nitroglycerin-as-an-anti-cancer-agent

Clinical Study: Repurposing Drugs in Oncology (ReDO)—nitroglycerin as an anti-cancer agent

Vidula Sukhatme, Gauthier Bouche, Lydie Meheus, Vikas P Sukhatme, Pan Pantziarka

27 Aug 2015

https://doi.org/10.3332/ecancer.2015.568

Abstract | Full Article | PDF

523-treatment-of-early-stage-her2-breast-cancer-an-evolving-field

Review: Treatment of early-stage HER2 breast cancer—an evolving field

Arlindo R Ferreira, Kamal S Saini, Otto Metzger-Filho

16 Apr 2015

https://doi.org/10.3332/ecancer.2015.523

Abstract | Full Article | PDF

521-repurposing-drugs-in-oncology-redo-itraconazole-as-an-anti-cancer-agent

Clinical Study: Repurposing Drugs in Oncology (ReDO)—itraconazole as an anti-cancer agent

Pan Pantziarka, Vidula Sukhatme, Gauthier Bouche, Lydie Meheus, Vikas P Sukhatme

15 Apr 2015

https://doi.org/10.3332/ecancer.2015.521

Abstract | Full Article | PDF

512-meeting-report-from-the-second-eurocanplatform-summer-school-on-translational-cancer-research-portugal-20-24-october-2014

Conference Report: Meeting report from the second EurocanPlatform summer school on translational cancer research, Portugal, 20–24 October 2014

Grazyna Lipowska-Bhalla

19 Feb 2015

https://doi.org/10.3332/ecancer.2015.512

Abstract | Full Article | PDF

More from ecancer